Valuation check: PTKFF's profit margin is 10.87%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for PTKFF is 10.87% as of March 2026. That compares with 11.25% in the prior-year period — down 3.4% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside PT Kalbe Farma Tbk's historical trend and sector peers before judging valuation or financial health.
Over the past year, PTKFF's profit margin moved from 11.25% to 10.87% — a 3.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PT Kalbe Farma Tbk's valuation or profitability profile.
Against Healthcare companies, PTKFF currently prints 10.87% for profit margin, while the sector average sits near 15.58%. That is roughly 30.3% below the sector mean. Large gaps often invite a closer look at PT Kalbe Farma Tbk's growth, margins, and balance sheet.
Profit Margin shows how effectively PT Kalbe Farma Tbk converts resources into returns. At 10.87%, PTKFF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 11.25% in the prior-year period — down 3.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PTKFF's profit margin (10.87%), review year-over-year change from 11.25%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.